European private equity firm Cinven has agreed to buy French medical diagnostics provider Labco SA for 1.2 billion euros ($1.31 billion), a person familiar with the deal told Reuters.
The deal could be announced as soon as Thursday, the person said.
A buyout deal for Labco comes two weeks after the company abandoned plans for a 545 million euro initial public offering on Euronext Paris, citing "volatility across global financial markets."
Cinven and Labco could not be reached immediately for comment.
Labco registered net sales of 650 million euros for 2014, with earnings before interest, taxation, depreciation and amortisation at 131 million euros and EBITDA margin at about 20 percent, according to the person familiar with the matter.
The Financial Times first reported the deal.
Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
Latest stories
Related stories
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
